(Q36216260)

12 August 2017

1 reference

title

Targeting endothelial dysfunction in hypertensive subjects (English)

1 reference

12 August 2017

0 references

Thuillez C

1

1 reference

PubMed ID

16075029

12 August 2017

Richard V

series ordinal

2

1 reference

12 August 2017

1 June 2005

1 reference

Journal of Human Hypertension

12 August 2017

1 reference

12 August 2017

19 Suppl 1

1 reference

12 August 2017

S21-5

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001889

12 August 2017

0 references

cites work

Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Increased endothelium--monocyte interactions in salt-sensitive hypertension: effect of L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Prognostic significance of endothelial dysfunction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

L-Arginine improves endothelial function in renal artery of hypertensive Dahl rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Does ADMA cause endothelial dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Oxygen free radicals in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Different effect of antihypertensive drugs on conduit artery endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

7 January 2021

Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

7 January 2021

Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

7 January 2021

Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

7 January 2021

Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

7 January 2021

Tetrahydrobiopterin and endothelial nitric oxide synthase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

7 January 2021

Eicosonoid metabolism and beta-adrenergic mechanisms in coronary arterial smooth muscle: potential compartmentation of cAMP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

7 January 2021

Alterations in nitric oxide synthase activity, superoxide anion generation, and platelet aggregation in systemic hypertension, and effects of celiprolol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

7 January 2021

Fixed-dose combination of perindopril with indapamide in spontaneously hypertensive rats: haemodynamic, biological and structural effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

7 January 2021

Mortality in congestive heart failure complicated by atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

7 January 2021

Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: effects of antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

7 January 2021

Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001889

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001889

1 reference

12 August 2017

1 reference

PubMed ID

16075029